Table I. Cytokine and Chemokine Response to Lipoplex Formulations.
Sphingosinebased | CpG – rich Plasmid | PEG-DSPE | DOTAP | Lipofectamine | |
---|---|---|---|---|---|
BLC | * | * | * | ||
C5 | * | * | * | ||
G-CSF | * | * | * | ||
GM-CSF | * | * | |||
I-309 | * | * | |||
Eotaxin | * | * | * | ||
sICAM-1 | * | ||||
IFN-gamma | * | * | |||
IL-1alpha | * | * | * | ||
IL-1beta | * | * | * | ||
IL-1ra | * | * | |||
IL-2 | * | * | |||
IL-3 | * | * | |||
IL-4 | * | ||||
IL-5 | * | * | * | ||
IL-6 | * | * | |||
IL-7 | * | * | * | * | |
IL-10 | * | * | |||
IL-13 | * | * | * | ||
IL-12p70 | * | ||||
IL-16 | * | * | |||
IL-17 | * | * | |||
IL-23 | * | * | * | ||
IL-27 | * | * | * | ||
IP-10 | * | * | * | ||
I-TAC | * | ||||
KC | * | * | * | * | |
M-CSF | * | * | * | ||
JE | * | * | |||
MCP-5 | * | * | |||
MIG | * | * | |||
MIP-1alpha | * | * | |||
MIP-1beta | * | * | |||
MIP-2 | * | * | |||
RANTES | * | ||||
SDF-1 | * | ||||
TNF-alpha | * | * |